These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2441050)

  • 1. Dissociation of hypolipidemic and antiplatelet actions from adverse myotonic effects of clofibric acid related enantiomers.
    Feller DR; Kamanna VS; Newman HA; Romstedt KJ; Witiak DT; Bettoni G; Bryant SH; Conte-Camerino D; Loiodice F; Tortorella V
    J Med Chem; 1987 Aug; 30(8):1265-7. PubMed ID: 2441050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues.
    Bettoni G; Loiodice F; Tortorella V; Conte-Camerino D; Mambrini M; Ferrannini E; Bryant SH
    J Med Chem; 1987 Aug; 30(8):1267-70. PubMed ID: 2441051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels.
    Conte-Camerino D; Mambrini M; DeLuca A; Tricarico D; Bryant SH; Tortorella V; Bettoni G
    Pflugers Arch; 1988 Nov; 413(1):105-7. PubMed ID: 2464159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.
    Esbenshade TA; Kamanna VS; Newman HA; Tortorella V; Witiak DT; Feller DR
    Biochem Pharmacol; 1990 Sep; 40(6):1263-74. PubMed ID: 2403380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stereospecific binding site regulates the C1- ion channel in rat skeletal muscle.
    Conte Camerino D; Tortorella V; Bettoni G; Bryant SH; De Luca A; Mambrini M; Tricarico D; Grasso G
    Pharmacol Res Commun; 1988 Dec; 20(12):1077-8. PubMed ID: 2463645
    [No Abstract]   [Full Text] [Related]  

  • 6. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions.
    De Luca A; Tricarico D; Wagner R; Bryant SH; Tortorella V; Conte Camerino D
    J Pharmacol Exp Ther; 1992 Jan; 260(1):364-8. PubMed ID: 1309879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives.
    Pusch M; Liantonio A; Bertorello L; Accardi A; De Luca A; Pierno S; Tortorella V; Camerino DC
    Mol Pharmacol; 2000 Sep; 58(3):498-507. PubMed ID: 10953042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action].
    Dănilă G; Nechifor M; Filip M; Păduraru I; Ifrim C; Grădinariu D; Papa V; Manolescu A; Bădescu A
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):127-32. PubMed ID: 3393745
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Ciprofibrate on platelet aggregation and fibrinolysis in patients with hypercholesterolaemia.
    Simpson IA; Lorimer AR; Walker ID; Davidson JF
    Thromb Haemost; 1985 Aug; 54(2):442-4. PubMed ID: 4082082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental pharmacological study of moroxybrate, a hypolipidaemic, antithrombotic, antiatheromatous agent.
    Moreau P; Jacotot B; Tillement JP
    J Pharm Pharmacol; 1987 Jan; 39(1):35-8. PubMed ID: 2880981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antiaggregatory activity in human platelets of a benzopyranone aci-reductone, clofibric acid, and a 2,3-dihydrobenzofuran analogue.
    Witiak DT; Kim SK; Romstedt K; Newman HA; Feller DR
    J Med Chem; 1986 Nov; 29(11):2170-4. PubMed ID: 3097315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU; Granzer E
    Artery; 1980; 8(5):475-81. PubMed ID: 7011266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of a new hypolipidemic agent, ciprofibrate.
    Arnold A; McAuliff MP; Beyler AL
    J Pharm Sci; 1979 Dec; 68(12):1557-8. PubMed ID: 529054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloride channels of skeletal muscle from developing, adult and aged rats are differently affected by enantiomers of 2-(p-chlorophenoxy) propionic acid.
    De Luca A; Tortorella V; Conte Camerino D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Dec; 346(6):601-6. PubMed ID: 1336571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
    Honorato Pérez J; Azanza Perea JR
    Rev Med Univ Navarra; 1982 Mar; 26(1):51-4. PubMed ID: 7111953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B; Gasparini Casari M; DiBlasio P; Zirilli E
    Arzneimittelforschung; 1981; 31(10a):1863-6. PubMed ID: 7032534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beclobrinic acid--a new hypolipidemic agent--inhibits in vitro human platelet activation by blocking prostaglandin synthesis.
    Anwer K; Gabis J; Romstedt K; Gojer C; Huzoor-Akbar
    Life Sci; 1985 Jul; 37(1):63-70. PubMed ID: 3925267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "The influence of conformational factors on the metabolic conjugation of aryloxyacetates"--a comment.
    Kennard CH; Smith G
    J Pharm Pharmacol; 1988 May; 40(5):380. PubMed ID: 2899641
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
    Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.